Supernus Pharmaceuticals
SUPN
$31.03
Share price
3.19%
Change (1 day)
-15.82%
Change (1 year)
Categories
Supernus Pharmaceuticals (SUPN) Fails to deliver data
Key failure to deliver metrics for Supernus Pharmaceuticals :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0 M
- Last 3 months FTD volume: $0.2 M
- Last year FTD volume: $2.29 M
Failures to deliver for Supernus Pharmaceuticals (SUPN) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Supernus Pharmaceuticals (SUPN) - since 2013
Volume in USD (price x number of shares), data since 2013Supernus Pharmaceuticals (SUPN) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.2 M | -92.99% |
| 2023 | $2.9 M | -42.08% |
| 2022 | $5.02 M | -61.53% |
| 2021 | $13.05 M | 190.05% |
| 2020 | $4.5 M | -65.28% |
| 2019 | $12.96 M | -51.62% |
| 2018 | $26.79 M | 40.71% |
| 2017 | $19.04 M | 70.75% |
| 2016 | $11.15 M | -71.48% |
| 2015 | $39.1 M | 794.53% |
| 2014 | $4.37 M | -87.63% |
| 2013 | $35.33 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.14 B | $0.60 B | 🇺🇸 USA |
 Abbott Laboratories ABT | $62.08 M | $0.14 B | 🇺🇸 USA |
 Eli Lilly LLY | $50.92 M | $0.12 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.19 B | $0.29 B | 🇺🇸 USA |
 Zogenix ZGNX | N/A | $54.53 M | 🇺🇸 USA |
 United Therapeutics UTHR | $0.18 M | $57.5 M | 🇺🇸 USA |